Published October 27, 2022 | Version v1
Journal article Open

FEATURES OF THE COLPOCYTOLOGICAL STATE AND BIOCENOSIS OF THE VAGINA IN MENOPAUSAL WOMEN WITH ATROPHIC VAGINITIS

Creators

  • 1. Bogomolets National Medical University, Kyiv, Ukraine
  • 2. Center of Women Health CH «Feofania», Kyiv, Ukraine
  • 3. SI "Luhansk State Medical University", Rivne, Ukraine

Description

The objective: to study and evaluate the colpocytological state of the mucous membrane and the biocenosis of the vagina in women with atrophic vaginitis (AV) before CO2 laser therapy.
Materials and methods. A prospective clinical and statistical examination of 160 patients with AV was conducted. The main group was formed from 55 women of menopausal age with clinical manifestations of AV, who were treated only by the therapy with CO2 laser. The comparison group included 40 women of menopausal age who had for the correction of AB manifestations CO2 laser therapy in combination with local hormonal therapy – suppositories which contain 0.5 mg of estriol.
The control group included 65 women of menopausal age who were treated with the therapy with the local application of suppositories with 0.5 mg of estriol once a day.
The standard hormonal colpocytology was performed in all the women to assess the colpocytological state of the vaginal mucosa.
Diagnostic test strips were used to determine the condition of the vagine (pH). In the case of a shift in the pH of the vaginal contents ≥ 4.4, the degree of vaginal purity and the number of leukocytes were studied using a microscopic examination. An amine test was performed to determine the presence of bacterial vaginosis in patients with AB. The microbiological study was performed using the “Femoflor-16” method.
Results. The hypoestrogenic and atrophic types of smears were found in all 160 (100.0 %) women. The inflammatory type of colpocytological smear was determined in 116 (72.5 %) patients, cytolytic type – in 14 (8.6 %), mixed type of vaginal smears – in 30 (18.6 %) persons.
In 126 (78.6 %) women, the pH index shifted to the alkaline side and ranged from 4.9 to 5.6, and the average value was 5.2±0.31. The bacterioscopic analysis of vaginal discharges indicates that in 83 (65.9 %) women with pathological pH values, the third degree of purity of the vaginal smear according to Herlin was found. In every third of women – 37 (29.4 %) – the presence of Candida fungi was determined. A significant decrease in the number of Lactobacillus spp. was established, a sufficient number of which was found in 9 (10.8 %) of the examined women. Facultative anaerobic microorganisms were found in 34 (40.6 %) women with AB.
Obligate anaerobic microflora – Gardnerella vaginalis in combination with Prevotella bivia and Porphyromonas spp., which was found in 23 (27.7 %) women, was in the first place among the detected microorganisms; Mobiluncus spp. in association with Corynebacterium spp. were in the second place in prevalence, and were determined in 18 (21.7 %) persons, in third place – Atopobium vaginae, which was diagnosed in 10 (12.0 %) of the examined women.
A qualitative analysis of the culture study results demonstrates a high level of cultivation of facultative anaerobic and obligate anaerobic microorganisms in women with AB, the quantitative value of which reached lg 3.1 – lg 3.9 CFU/ml and lg 3.4 – lg 4.7 CFU/ ml, respectively.
Conclusions. A one hundred percent predominance of hypoestrogenic and atrophic types of colpocytological smears was established in women with atrophic vaginitis. The frequency of detection of inflammatory, cytolytic and mixed types of colpocytological smears was 116 (72.5 %) cases, 14 (8.6 %) cases and 30 (18.6 %) cases, respectively. The initial examination of the vaginal pH demonstrates a shift in the alkaline side of this indicator in 126 (78.6 %) women, which ranged from 4.9 to 5.6, and the average value was 5.2±0.31.
Bacterioscopic analysis of vaginal discharges established that in 83 (65.9 %) women with pathological pH values there was the third degree of vaginal purity according to Herlin. A significant decrease in the number of lactobacilli Lactobacillus spp. (lg 2.1±0.21 CFU/ml) on the background of an increase in the level of obligate anaerobic microorganisms in the microflora – Gardnerela vaginalis in associations with Prevotella bivia+Porphyromonas spp (lg 4.7±0.38 CFU/ml) in combination with Mobiluncus spp. in association with Corynebacterium spp. (lg 4.0±0.35 CFU/ml), and Atopobium vaginea (lg 3.4±0.28 CFU/ml) were determined.

Files

Features of the colpocytological state and biocenosis of the vagina in menopausal women with atrophic vaginitis.pdf

Files (405.2 kB)

Additional details

References

  • Gaspar E, Eddemo G, Brendi KH. Fraktsionnyy SO2-lazer: minimal'no invazivnyy metod omolozheniya vlagalishcha. Plasticheskaya khirurgiya kosmetol. 2012;(2):325-9.
  • Glazunova AV, Yureneva SV, Yermakova YEI. Vaginalnaya atrofiya. Akusherstvo i ginekol. 2014;(2):21-6.
  • Kalugina LV, Tatarchuk TF, Shakalo IN, et al. Nespetsificheskiy vulvovaginit smeshannoy etiologii: mestnoye lecheniye – terapiya vybora. Reprod yendokrinol. 2016;27(1):94-100.
  • Kuznetsova IV, Chushkov YUV, Ishchenko AI. Rolmestnogo ispolzovaniya estriola v optimizatsii iskhodov operativnogo lecheniya opushcheniya polovykh organov u patsiyentok v peri- i postmenopauze. Akusherstvo ginekol. 2015;(19):2-6.
  • Arunkalaivanan A, Kaur H, Onuma O. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence. Int Urogynecol J. 2017;28(5):681-5. doi: 10.1007/s00192-017-3282-y.
  • Bojanini JF, Mejia AM. Laser treatment of vaginal atrophy in postmenopause and post-gynecological cancer patients. J Laser Health Acad. 2014;(1):65-71.
  • Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Kagan R, Kagan R, et al. Management of genitourinary syndrome of menopause in women with high risk for breast cancer: consensus recommendations from The North American Monopause Society and the International Society for the Study of Women's Sexual Care. Menopause: J North Am Menopause Soc. 2018;25(6):1-13. doi: 10.1097/GME.0000000000001121.
  • Domoney C. Treatment of vaginal atrophy. Womens Health. 2014;(10):191-200.
  • Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition. Climacteric. 2016;19(2):151-61. doi: 10.3109/13697137.2015.1124259.
  • Fistonic I, Manestar M, Perovic D, Sorta-Bilajac TI, Fistonic N, Maletic D, et al. Laser vaginal tightening for sexual dysfunction. Climacteric. 2011;14(1):85.
  • Fistonic N, Fistonic I, Lukanovic A, Findri GS, Sorta Bilajac TI, Franic D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015;18(1):37-42. doi: 10.3109/13697137.2015.1071126.
  • Gaspar A, Addamo G, Brandi H. Vaginal fractional CO2 laser: A minimally invasive option for vaginal rejuvenation. Am J Cosmetic Surg. 2011;28(3):156-62.
  • Griebling TL, Liao Z, Smith PG. Systemic and topical hormone therapies reduce vaginal innervation density in post-menopausal women. Menopause. 2012;19(6):630-5. doi: 10.1097/gme.0b013e31823b8983.
  • Gaviria JE, Lanz JA. Laser vaginal tightening (LVT) - evaluation of a new non-invasive laser treatment of vaginal relaxation syndrome. J Laser Health Acad. 2021;(1):59-66.
  • Handa VL. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol. 1994;8(2):215-23.
  • Hummelen R. Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One. 2011;6(11):e26602c. doi: 10.1371/journal.pone.0026602.
  • Hutchinson-Colas J, Segal S. Genitourinary syndrome of menopause and the use of laser therapy. Maturitas. 2015;82(4):342-5. doi: 10.1016/j.maturitas.2015.08.001.
  • Hyun-Kyung K, So-Yeon K, Youn-Jee C, Jang-Heub K, Mee-Ran K. The Recent Review of the Genitourinary Syndrome of Menopause. J Menopausal Med. 2015;21:65-71. doi: 10.6118/jmm.2015.21.2.65
  • Magnani LR. Schweiger ES. Fractional CO2 lasers for the treatment of atrophic acne scars: a review of the literature. J Cosmet Laser Ther. 2014;16(2):48-56. Fractional CO2 lasers for the treatment of atrophic acne scars: a review of the literature.
  • Nappi RE, Kokot- Kierepa M. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233-8. doi: 10.1016/j.maturitas.2010.08.001.
  • Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17:3-9. doi: 10.3109/13697137.2013.871696.
  • Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. J Sex Med. 2014;11:2865-72. doi: 10.1097/GME.0000000000000329.
  • Raghunandan C, Agrawal S, Dubey P, Choudhury M, Jain A. A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. J Sex Med. 2010;7:1284-90. doi: 10.1111/j.1743-6109.2009.01667.x.
  • Sturdee DW, Panay N, Sturdee W. Recommendations for the management of postmenopausal vaginal atrophy. International Menopause Society Writing Group. Climacteric. 2010;13(6):509-31. doi: 10.3109/13697137.2010.522875.
  • Stefano S, Stavros A, Massimo C. The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Curr Opin Obstet Gynecol. 2015;27(6):504-8. doi: 10.1097/GCO.0000000000000230.